Drugs / ProteoCIT®
last change Jul 2021 re-read 3 minutes ago

ProteoCIT®

Developed for
chronic obstructive pulmonary disease
Investigated by
University Hospital, Grenoble

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03694964 Jan 2019 chronic obstructive pulmonary disease University Hospital, Grenoble Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ProteoCIT “Citrulline (ProteoCIT®) 10 mg by day during 45 days” NCT03694964 ↗
1

NCT03694964 ↗

Route Oral “Effects of Oral Citrulline Supplementation” NCT03694964 ↗